Gabriela Věchetová1,2, Tomáš Nikolai3,4, Matěj Slovák1, Zuzana Forejtová1, Marek Vranka5, Eva Straková1,2, Tiago Teodoro6,7, Evžen Růžička1, Mark J Edwards6, Tereza Serranová1. 1. Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Kateřinská 30, 120 00, Prague 2, Czech Republic. 2. National Institute of Mental Health, Klecany, Czech Republic. 3. Department of Neurology and Centre of Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Kateřinská 30, 120 00, Prague 2, Czech Republic. tomas.nikolai@vfn.cz. 4. Department of Psychology, Charles University, Prague, Czech Republic. tomas.nikolai@vfn.cz. 5. Department of Psychology, Charles University, Prague, Czech Republic. 6. Neuroscience Research Centre, Institute of Molecular and Clinical Sciences, St George's University of London, London, UK. 7. Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, Portugal.
Abstract
OBJECTIVE: Our objective was to assess cognitive functioning across multiple cognitive domains using a standardised neuropsychological battery in patients with motor functional neurological disorders (mFND). METHODS: Thirty patients with clinically established mFND and 30 age-, sex- and education-matched control subjects underwent a thorough neuropsychological assessment evaluating (1) attention including processing speed, (2) executive functions including working memory, (3) short-term memory, (4) speech and language and (5) visuospatial functions. Performance validity tests (PVT) and self-report measures of depression, anxiety and cognitive complaints were included in the assessment. Only patients with valid test performance were included in the analysis. RESULTS: Three patients scored below the cut-off scores in PVT. Patients performed significantly worse than controls in the following areas: (1) the attention domain which included a slow processing speed (p = 0.005, Cohen's d = 0.89), (2) executive functions (p = 0.01, Cohen's d = 0.88) and (3) speech and language domains (p = 0.025, Cohen's d = 0.77). Patients with mFND showed greater intra-individual variability in cognitive performance (p = 0.005, Cohen's d = 0.94). Cognitive impairments were independent of depressive symptoms, which were higher in mFND patients. CONCLUSION: This study revealed both subjective and objective cognitive impairment in patients with mFND. The neuropsychological profile in mFND was characterised primarily by attentional impairment including a slow processing speed and a high intra-individual variability in cognitive performance. Cognitive impairment was associated with a valid test performance, highlighting that the deficits observed were not likely to be explained by a lack of effort in the patient group. Attention is considered to play a key role in mFND pathophysiology, and the results suggest that such impairments are objectively measurable.
OBJECTIVE: Our objective was to assess cognitive functioning across multiple cognitive domains using a standardised neuropsychological battery in patients with motor functional neurological disorders (mFND). METHODS: Thirty patients with clinically established mFND and 30 age-, sex- and education-matched control subjects underwent a thorough neuropsychological assessment evaluating (1) attention including processing speed, (2) executive functions including working memory, (3) short-term memory, (4) speech and language and (5) visuospatial functions. Performance validity tests (PVT) and self-report measures of depression, anxiety and cognitive complaints were included in the assessment. Only patients with valid test performance were included in the analysis. RESULTS: Three patients scored below the cut-off scores in PVT. Patients performed significantly worse than controls in the following areas: (1) the attention domain which included a slow processing speed (p = 0.005, Cohen's d = 0.89), (2) executive functions (p = 0.01, Cohen's d = 0.88) and (3) speech and language domains (p = 0.025, Cohen's d = 0.77). Patients with mFND showed greater intra-individual variability in cognitive performance (p = 0.005, Cohen's d = 0.94). Cognitive impairments were independent of depressive symptoms, which were higher in mFND patients. CONCLUSION: This study revealed both subjective and objective cognitive impairment in patients with mFND. The neuropsychological profile in mFND was characterised primarily by attentional impairment including a slow processing speed and a high intra-individual variability in cognitive performance. Cognitive impairment was associated with a valid test performance, highlighting that the deficits observed were not likely to be explained by a lack of effort in the patient group. Attention is considered to play a key role in mFND pathophysiology, and the results suggest that such impairments are objectively measurable.
Authors: Ondrej Bezdicek; Hana Stepankova; Ladislav Moták; Bradley N Axelrod; John L Woodard; Marek Preiss; Tomáš Nikolai; Evžen Růžička; Amir Poreh Journal: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn Date: 2013-12-17
Authors: Priyanka R Alluri; Juliet Solit; Catherine L Leveroni; Katherine Goldberg; Julia V Vehar; Lauren E Pollak; Mary K Colvin; David L Perez Journal: Cogn Behav Neurol Date: 2020-06 Impact factor: 1.600
Authors: Ondrej Bezdicek; Ladislav Motak; Bradley N Axelrod; Marek Preiss; Tomas Nikolai; Martin Vyhnalek; Amir Poreh; Evzen Ruzicka Journal: Arch Clin Neuropsychol Date: 2012-09-30 Impact factor: 2.813
Authors: E Barbeau; M Didic; E Tramoni; O Felician; S Joubert; A Sontheimer; M Ceccaldi; M Poncet Journal: Neurology Date: 2004-04-27 Impact factor: 9.910
Authors: Lars de Vroege; Iris Koppenol; Willem Johan Kop; Madelon M E Riem; Christina Maria van der Feltz-Cornelis Journal: J Neuropsychol Date: 2020-03-29 Impact factor: 2.864